c-MET Inhibition: Novel Treatment for Sporadic and MEN1-associated GEP NET.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of molecular endocrinology"
DOI: 10.1530/jme-20-0020
Abstract: Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) comprise a heterogenous and diverse group of neoplasms arising from a common neuroendocrine cell origin. The majority of these tumors occur sporadically while ~20% manifest within the context of hereditary… read more here.
Keywords: met inhibition; men1 associated; sporadic men1; men1 ... See more keywords